v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net income (loss) $ 30,586 $ (314,925) $ (153,040)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 85,362 93,807 97,344
Non-cash interest 9,994 8,731 4,903
Amortization of deferred financing costs 847 995 187
Losses from investments in investees 480 2,900 14,497
Equity-based compensation – employees and non-employees 8,947 13,421 21,761
Asset impairment charges 0 92,399 21,778
Realized loss (gain) on disposal of fixed assets and sales of equity securities and other (10,681) 739 46
Change in fair value of equity securities and derivative instruments and other (101) 8,748 (6,524)
Change in fair value of contingent consideration (3,989) (14,854) (16,816)
Deferred income tax provision (benefit) 15,640 4,324 (35,133)
Changes in assets and liabilities, net of the effects of acquisitions:      
Accounts receivable, net (150,437) 7,376 20,397
Inventory, net (77,642) (12,133) 4,590
Other current assets and prepaid expenses 20,504 (11,486) 2,276
Other assets (447) 409 (69)
Accounts payable 37,159 15,636 (26,083)
Foreign currency measurement (3,185) (71) 294
Contract liabilities (5,389) (69,302) (61,264)
Accrued expenses and other liabilities 81,828 764 1,715
Net cash provided by (used in) operating activities 39,476 (172,522) (109,141)
Effect of exchange rate changes on cash and cash equivalents 686 (477) (676)
Net increase (decrease) in cash and cash equivalents (13,241) (11,021) 4,974
Cash and cash equivalents at beginning of period 85,452 96,473 91,499
Cash and cash equivalents at end of period 72,211 85,452 96,473
Cash flows from financing activities:      
Issuance of common stock 0 76,062 92,500
Issuance of 2023 Convertible Notes, including to related parties 0 200,293 55,000
Debt issuance costs 0 (7,762) 0
Proceeds from the exercise of Common Stock options and warrants 756 (3) 1,174
Borrowings on lines of credit 1,107,866 294,780 26,917
Repayments of lines of credit (1,143,698) (359,322) (34,681)
Redemption of 2033 Senior Notes 0 (28,800) 0
Net cash (used in) provided by financing activities (35,076) 175,248 140,910
Cash flows from investing activities:      
Investments in investees 0 (1,200) (1,000)
Proceeds from sale of investments 15,110 0 1,516
Proceeds from the sale of property, plant and equipment 245 671 1,223
Capital expenditures (33,682) (12,741) (27,858)
Net cash used in investing activities (18,327) (13,270) (26,119)
SUPPLEMENTAL INFORMATION:      
Interest paid 10,908 11,873 2,076
Income taxes paid, net of refunds (903) 2,667 (1,410)
Operating lease right-of-use assets due to adoption of ASU No. 2016-02 0 39,380 0
Operating lease liabilities due to adoption of ASU No. 2016-02 0 39,703 0
Non-cash financing:      
Shares issued upon the conversion of - Common Stock options and warrants, surrendered in net exercise $ 0 $ 20 $ 806

Source